Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01167218 · ClinicalTrials.gov registry record
Study to Assess Platelet Dysfunction With Verify Now Assay
A clinical trial, sponsored by NYU Langone Health.
- Completed
- Registry status
- 79
- Enrollment target
NCT01167218 is a clinical trial that has completed, run by NYU Langone Health. The registered enrollment target is 79 participants.
The verdict
NCT01167218 has completed, sponsored by NYU Langone Health.
- COMPLETED
- Registry status
- 79 participants
- Enrollment target
Study Summary
The purpose of this study is to conduct a Verify now assay to detect platelet aggregation defects in patients with Myelodysplastic syndrome(MDS), immune thrombocytopenia purpura (ITP) and myeloproliferative disorders (MPD).
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 79 participants |
| Start Date | 2009-12 |
| Est. Completion | 2012-02 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01167218
The ClinicalTrials.gov registry entry for NCT01167218 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 79 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is NYU Langone Health, which has 1,164 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 0 interventions.
NCT01167218 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01167218 about?
NCT01167218 is a clinical study titled "Study to Assess Platelet Dysfunction With Verify Now Assay". The purpose of this study is to conduct a Verify now assay to detect platelet aggregation defects in patients with Myelodysplastic syndrome(MDS), immune thrombocytopenia purpura (ITP) and myeloproliferative disorders (MPD).
What is the current status of trial NCT01167218?
This trial is currently completed. The enrollment target is 79 participants. The study started on 2009-12. Estimated completion is 2012-02.
Who is sponsoring clinical trial NCT01167218?
This trial is sponsored by NYU Langone Health, which has 1,164 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.